Biomarkers of Oxidative Stress and Cataract. Novel Drug Delivery Therapeutic Strategies Targeting Telomere Reduction and the Expression of Telomerase Activity in the Lens Epithelial Cells with N-Acetylcarnosine Lubricant Eye Drops: Anti-Cataract which Helps to Prevent and Treat Cataracts in the Eyes of Dogs and other Animals

By  

Current Drug Delivery, Vol. 11, Iss. 1, 2014-02 ,pp. : 24-61

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Peroxidation and Cataracts: N-Acetylcarnosine as a Therapeutic Tool to Manage Age-Related Cataracts in Human and in Canine Eyes

By Babizhayev M.A.   Deyev A.I.  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 125-139

Adis International

Access to resources Recommend Favorite

Ocular Drug Metabolism of the Bioactivating Antioxidant N-acetylcarnosine for Vision in Ophthalmic Prodrug and Codrug Design and Delivery

By Babizhayev Mark  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 10, 2008-10 ,pp. : 1071-1089

Informa Healthcare

Access to resources Recommend Favorite

State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases

By  

Current Clinical Pharmacology, Vol. 4, Iss. 1, 2009-01 ,pp. : 4-37

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of N-Acetylcarnosine in the Treatment of Cataracts

By Babizhayev M.A.  

Drugs in R&D, Vol. 3, Iss. 2, 2002-02 ,pp. : 87-103

Adis International

Access to resources Recommend Favorite